Ticagrelor and central sleep apnea: analysis of VigiBase, the WHO pharmacovigilance database

B. Revol (Grenoble, France), I. Jullian-Desayes (Grenoble, France), R. Tamisier (Grenoble, France), V. Puel (Bordeaux, France), M. Mallaret (Grenoble, France), M. Joyeux-Faure (Grenoble, France), J. Pépin (Grenoble, France)

Source: International Congress 2018 – Pathophysiological aspects of sleep-disordered breathing: intermittent hypoxia
Session: Pathophysiological aspects of sleep-disordered breathing: intermittent hypoxia
Session type: Oral Presentation
Number: 3291
Disease area: Sleep and breathing disorders

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
B. Revol (Grenoble, France), I. Jullian-Desayes (Grenoble, France), R. Tamisier (Grenoble, France), V. Puel (Bordeaux, France), M. Mallaret (Grenoble, France), M. Joyeux-Faure (Grenoble, France), J. Pépin (Grenoble, France). Ticagrelor and central sleep apnea: analysis of VigiBase, the WHO pharmacovigilance database. 3291

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Baclofen and sleep apnoea syndrome: analysis of VigiBase, the WHO pharmacovigilance database
Source: Eur Respir J, 51 (1) 1701855; 10.1183/13993003.01855-2017
Year: 2018



Clusters of sleep apnea phenotypes: A European perspective from the ESADA database
Source: International Congress 2019 – Challenging issues in the clinical aspects of sleep-disordered breathing
Year: 2019



The method for diagnosis matters in sleep apnea. A systematic analysis of polygraphy and polysomnography data in the European Sleep Apnea Database (ESADA)
Source: Annual Congress 2012 - Diagnostics in OSA: from polygraphy to genetics and cancer
Year: 2012

The European Sleep Apnoea Database (ESADA): report from 22 European sleep laboratories
Source: Eur Respir J 2011; 38: 635-642
Year: 2011



Rates of CPAP therapy termination in different obstructive sleep apnoea patient phenotypes: analysis of the French nationwide health claims database
Source: Virtual Congress 2021 – Different treatment modalities and impact of comorbidities on sleep disordered breathing
Year: 2021



Positional obstructive sleep apnea in the European Sleep Apnoea Database (ESADA) study
Source: International Congress 2018 – Treatments that can serve as an alternative to positive airway pressure (PAP)
Year: 2018

Sleep apnoea management in Europe during the COVID-19 pandemic: data from the European Sleep Apnoea Database (ESADA)
Source: Eur Respir J, 55 (6) 2001323; 10.1183/13993003.01323-2020
Year: 2020



Obstructive sleep apnea and cardiovascular risk markers in community individuals- Results from the sleep apnea and vascular evaluation (SAVE) study
Source: International Congress 2016 – Effects of hypoxia and sleep apnoea on the lung, heart, and vessels
Year: 2016


Determinants of daytime sleepiness in mild obstructive sleep apnoea syndrome. Data from the European Sleep Apnoea Database (ESADA) cohort study.
Source: International Congress 2018 – Sleep-disordered breathing: cardiovascular consequences, epidemiology, phenotypes and comorbidities
Year: 2018



Telehealthcare interventions in the management of obstructive sleep apnoea hypopnoea syndrome (OSAHS) in continuous positive airway pressure (CPAP) users - A systematic review
Source: International Congress 2016 – Treatment options for obstructive sleep apnoea and obesity hypoventilation
Year: 2016


Treatment effects of sleep apnoea: where are we now?
Source: Eur Respir Rev 2007; 16: 146-168
Year: 2007



Reversal of central sleep apnoea with change from methadone to buprenorphine-naloxone: a case report
Source: Eur Respir J 2015; 46: 1202-1205
Year: 2015


Obstructive sleep apnea is an independent predictor for dyslipidemia: Data from the European Sleep Apnea Database (ESADA)
Source: International Congress 2017 – Central sleep apnoea: consequences and comorbidities of obstructive sleep apnoea
Year: 2017



Mild obstructive sleep apnoea (OSA) and arterial hypertension in the EuropeanSleep Apnoea Database (ESADA) cohort study.
Source: International Congress 2018 – Epidemiology, phenotypes and cardiometabolic comorbidities of obstructive sleep apnoea
Year: 2018



Utility of split-night and multiple-split-night study protocols in the evaluation of central sleep apnea patients
Source: Eur Respir J 2006; 28: Suppl. 50, 419s
Year: 2006

Telemedicine in Obstructive Sleep Apnea (OSA) patients with limited internet knowledge to control their CPAP: CLIC-CPAP. Justification, design and methodology
Source: International Congress 2017 – Efficacy of and compliance with obstructive sleep apnoea treatment
Year: 2017

Obstructive sleep apnoea hypopnoea syndrome (OSAHS) service - streamline of workflow by digital solutions
Source: Sleep and Breathing Conference 2021
Year: 2021

Residual daytime sleepiness (RES) in CPAP-treated obstructive sleep apnea (OSA) patients in the European Sleep Apnea Database (ESADA)
Source: Virtual Congress 2021 – From phenotyping to different diagnostic tools for sleep breathing disorders
Year: 2021

Evaluation of the STOP-BANG questionnaire as a screening tool for sleep apnea in a sleep medicine center
Source: Annual Congress 2013 –Sleep disordered breathing in special situations III
Year: 2013

Over diagnosis of sleep apnoea: A comparison of three common ambulatory sleep polygraphs
Source: International Congress 2016 – Clinical presentation, daytime symptoms, and screening of obstructive sleep apnoea
Year: 2016